Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...
The head of the FDA’s artificial-intelligence-focused Digital Center of Excellence, Troy Tazbaz, is departing the agency ...
Dr. Sara Brenner, who has been FDA CDRH's in vitro diagnostics chief medical officer, is serving as acting commissioner of the agency.
Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading key policies on artificial ...
MyChesCo on MSN6mon
FDA Opens Search for New CDRH DirectorWASHINGTON, D.C. — The Food and Drug Administration (FDA) has launched a national search for a new Director for the Center ...
Among the wave of guidance documents issued by the U.S. Food and Drug Administration (“FDA” or the “Agency”) in the first week of 2025 were ...
The website changes raise concerns about “the interference of politics with the study and the practice” of science and ...
GlobalData on MSN6d
FDA issues cybersecurity risk alert over Contec patient monitorThe FDA says the cybersecurity vulnerabilities identified may put patients at risk when the device is connected to the ...
The FDA first warned about problems with pulse oximeter accuracy in 2021. CDRH had listed draft guidance on pulse oximeters among its priorities for the 2024 fiscal year but missed the cutoff.
The FDA has tapped Sara Brenner to serve as acting commissioner as it awaits new leadership from the Trump administration to ...
Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading on policies involving artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback